Home > Boards > US OTC > Biotechs > Fortress BioTechnology (FBIO)

Chart of FBIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
conix Member Profile
 
Followed By 166
Posts 26,133
Boards Moderated 6
Alias Born 10/10/05
160x600 placeholder
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol GlobeNewswire Inc. - 12/11/2019 8:30:10 AM
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 11/4/2019 7:30:00 AM
Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development GlobeNewswire Inc. - 10/28/2019 8:30:05 AM
Avenue Therapeutics to Present Phase 3 Bunionectomy Study of IV Tramadol at the American Society of Anesthesiologists Annual ... GlobeNewswire Inc. - 10/18/2019 8:30:05 AM
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 8/14/2019 7:30:00 AM
Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors GlobeNewswire Inc. - 8/1/2019 8:00:00 AM
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Manageme... GlobeNewswire Inc. - 6/3/2019 7:00:00 AM
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 5/13/2019 7:30:00 AM
Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors GlobeNewswire Inc. - 4/30/2019 7:30:00 AM
Market Trends Toward New Normal in Colgate-Palmolive, Nucor, NeoPhotonics, Piper Jaffray Companies, The Ensign Group, and For... GlobeNewswire Inc. - 4/3/2019 8:45:00 AM
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights GlobeNewswire Inc. - 3/12/2019 7:30:00 AM
Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary) GlobeNewswire Inc. - 2/11/2019 7:30:00 AM
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for th... GlobeNewswire Inc. - 12/19/2018 8:00:00 AM
conix   Tuesday, 05/07/19 10:45:06 AM
Re: swampboots post# 27
Post # of 62 
Chart of FBIO



Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist